BamSEC and AlphaSense Join Forces
Learn More

Enzo Biochem Inc. – Plans of Reorganization, Merger, Acquisition or Similar

Formerly OTC: ENZB

Plans of Reorganization, Merger, Acquisition or Similar Filter

EX-2.1
from 8-K 78 pages Agreement and Plan of Merger by and Among Bethpage Parent, Inc., Bethpage Merger Sub, Inc. and Enzo Biochem, Inc. Dated as of June 23, 2025
12/34/56
EX-2.1
from DEFA14A 78 pages Agreement and Plan of Merger by and Among Bethpage Parent, Inc., Bethpage Merger Sub, Inc. and Enzo Biochem, Inc. Dated as of June 23, 2025
12/34/56
EX-2.1
from 8-K 10 pages Amendment No. 1 to Asset Purchase Agreement
12/34/56
EX-2.1
from DEFA14A 111 pages Asset Purchase Agreement Dated as of March 16, 2023 by and Among Laboratory Corporation of America Holdings, Enzo Clinical Labs, Inc. and Enzo Biochem, Inc
12/34/56
EX-2.1
from 8-K 111 pages Asset Purchase Agreement Dated as of March 16, 2023 by and Among Laboratory Corporation of America Holdings, Enzo Clinical Labs, Inc. and Enzo Biochem, Inc
12/34/56
EX-2.1
from 8-K 71 pages Asset Purchase Agreement by and Among Enzo Life Sciences, Inc., Enzo Life Sciences Acquisition, Inc., Assay Designs, Inc., Ampersand 2001 Limited Partnership and Ampersand 2001 Companion Fund Limited Partnership Dated: As of March 12, 2009
12/34/56
EX-2.1
from 8-K 99 pages Stock and Asset Purchase Agreement by and Among Enzo Biochem, Inc. Enzo Life Sciences, Inc. Biomol International, Inc. Axxora (Uk) Ltd. Biomol International, L.P., Biofiniti, L.L.C., Biomol Research Laboratories, Inc., Mamhead Holding Co., LLC, Robert E. Zipkin, PH.D. Ira M. Taffer, PH.D. Paul W. Sheppard, PH.D. and Ian M. Varndell, PH.D. Dated: As of May 8, 2008 Stock and Asset Purchase Agreement
12/34/56
EX-2.1
from 8-K >50 pages Plan of reorganization, merger, acquisition or similar
12/34/56